ADL- Training for Patients With Chronic Obstructive Pulmonary Disease (COPD)
Primary Purpose
Chronic Obstructive Pulmonary Disease
Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
ADL training
Sponsored by
About this trial
This is an interventional health services research trial for Chronic Obstructive Pulmonary Disease focused on measuring COPD, Pulmonary Rehabilitation, ADL-Training, COPD Rehabilitation
Eligibility Criteria
Inclusion Criteria:
- COPD
- Referred for rehabilitation
- Age > 18 years
- Symptoms affecting ADL function
- 6 minute walk distance (6MWD) < 400 meters
Exclusion Criteria:
- Patients who smokes or has smoked during the last three months.
- LTOT
- Patients who has another disability
- Patients who can't read or speak Norwegian
Sites / Locations
- Glittreklinikken
- Glittreklinikken
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
1: Standard rehabilitation programme
2. Additional ADL training
Arm Description
Outcomes
Primary Outcome Measures
Canadian Occupational Performance Measure(COPM) - Self-perception of occupational performance and satisfaction.
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00887705
Brief Title
ADL- Training for Patients With Chronic Obstructive Pulmonary Disease (COPD)
Official Title
Activities of Daily Living (ADL)-Training for Patients With Chronic Obstructive Pulmonary Disease (COPD)
Study Type
Interventional
2. Study Status
Record Verification Date
June 2010
Overall Recruitment Status
Completed
Study Start Date
May 2009 (undefined)
Primary Completion Date
February 2010 (Actual)
Study Completion Date
June 2010 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
LHL Helse
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
ADL training of copd patients results in better execution of activities of daily living.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Obstructive Pulmonary Disease
Keywords
COPD, Pulmonary Rehabilitation, ADL-Training, COPD Rehabilitation
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
24 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1: Standard rehabilitation programme
Arm Type
No Intervention
Arm Title
2. Additional ADL training
Arm Type
Experimental
Intervention Type
Behavioral
Intervention Name(s)
ADL training
Intervention Description
The control group gets the standard rehabilitation programme which includes one hour ADL- training. The experimental group also gets the standard rehabilitation program, but instead of one hour they get an additional five hours ADL- training.
Primary Outcome Measure Information:
Title
Canadian Occupational Performance Measure(COPM) - Self-perception of occupational performance and satisfaction.
Time Frame
Baseline, 4 weeks; 3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
COPD
Referred for rehabilitation
Age > 18 years
Symptoms affecting ADL function
6 minute walk distance (6MWD) < 400 meters
Exclusion Criteria:
Patients who smokes or has smoked during the last three months.
LTOT
Patients who has another disability
Patients who can't read or speak Norwegian
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Morten S Ryg, Dr philos
Organizational Affiliation
LHL Helse
Official's Role
Study Director
Facility Information:
Facility Name
Glittreklinikken
City
Hakadal
State/Province
Akershus
ZIP/Postal Code
1485
Country
Norway
Facility Name
Glittreklinikken
City
Hakadal
ZIP/Postal Code
1485
Country
Norway
12. IPD Sharing Statement
Links:
URL
http://www.lhl.no
Description
Site of LHL (Norwegian association for lung and heart disease patients). Glittreklinikken is listed as part of the organization
Learn more about this trial
ADL- Training for Patients With Chronic Obstructive Pulmonary Disease (COPD)
We'll reach out to this number within 24 hrs